Drug Trial Radar · NCT07562178
Pemafibrate for Symptomatic ICAS RCT
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
270
Planned (sponsor's estimate)
Start
May 26, 2026
Primary completion
Mar 31, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Tokyo Women's Medical UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Kowa Company, Ltd.
- First posted
- May 1, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn whether pemafibrate can help prevent worsening of intracranial arterial stenosis (ICAS) in patients who have symptomatic ICAS and high triglycerides (TG) levels after ischemic stroke or transient ischemic attack (TIA). The main questions this study aims to answer are: 1. Does pemafibrate lower the chance that ICAS gets worse over 12 months? 2. Does pemafibrate improve TG levels and other vascular risk markers? 3. What are the effects of pemafibrate on vascular events, functional outcomes, and safety over 12 months? Researchers will compare a pemafibrate group with a non-pemafibrate group to see whether pemafibrate helps prevent progression of ICAS. This is an open-label, randomized, parallel-group trial. That means participants are assigned by chance to 1 of 2 groups, and both the researchers and participants know which group was assigned. Participants in both groups will continue to receive standard stroke care, including antithrombotic therapy and management of vascular risk factors such as blood pressure, low-density lipoprotein cholesterol, diabetes, and smoking. Participants may be eligible if they are 18 years or older, have clinically stable ischemic stroke or TIA, have 50% to 99% stenosis in a symptomatic intracranial artery on contrast-enhanced CT angiography (CTA), and have elevated fasting (\>=150 mg/dL) or non-fasting (\>=175 mg/dL) TG levels. Some people will not be eligible, such as those with ICAS due to non-atherosclerotic arterial disease, severe extracranial carotid stenosis, recent intravenous thrombolysis or mechanical thrombectomy, planned revascularization, contraindications to pemafibrate or iodinated contrast media, dialysis, or pregnancy. Participants will: * Be randomly assigned to a pemafibrate group or a non-pemafibrate group * Take pemafibrate for 12 months if assigned to the pemafibrate group, with possible dose adjustment based on TG levels and kidney function * Have blood tests and clinical assessments at baseline and during follow-up * Undergo brain CTA at study entry and again at 12 months * Undergo brain MRI/MRA and vascular tests such as ankle brachial index, cardio ankle vascular index, and pulse wave velocity according to the study schedule * Be followed for vascular events, functional outcome, and adverse events for 1 year
Conditions
- Intracranial Atherosclerotic Disease (ICAD)
- Hypertriglyceridaemia
- Stroke (CVA) or TIA
Interventions
PemafibrateDrug
Participants in this arm will receive pemafibrate in addition to standard medical therapy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression in intracranial arterial stenosis on CTA at 12 months from enrollment (progression vs. no progression [no change or improvement])Time frame: Baseline and 12 months
Locations
42 sites in 1 country. Site status is shown where the registry gives one.
Fujita Health University Hospital
Toyoake, Aichi-ken, Japan · Recruiting
Tokyo Women's Medical University Yachiyo Medical Center
Yachiyo, Chiba, Japan · Recruiting
University of Fukui Hospital
Yoshida, Fukui, Japan · Not yet recruiting
Brain Attack Center Ota Memorial Hospital
Fukuyama, Hiroshima, Japan · Recruiting
Hiroshima City Hiroshima Citizens Hospital
Hiroshima, Hiroshima, Japan · Recruiting
Kobe City Medical Center General Hospital
Kobe, Hyōgo, Japan · Recruiting
University of Tsukuba Hospital
Tsukuba, Ibaraki, Japan · Recruiting
Iwate Medical University Hospital
Hizume, Iwate, Japan · Recruiting
Kagoshima City Hospital
Kagoshima, Kagoshima-ken, Japan · Not yet recruiting
Kagoshima Medical Center
Kagoshima, Kagoshima-ken, Japan · Recruiting
Tokai University Hopital
Isehara, Kanagawa, Japan · Recruiting
Nippon Medical School Musashikosugi Hospital
Kawasaki, Kanagawa, Japan · Recruiting
Kumamoto University Hospital
Kumamoto, Kumamoto, Japan · Recruiting
Japanese Red Cross Kumamoto Hospital
Kumamoto, Kumamoto, Japan · Not yet recruiting
Japanese Red Cross Kyoto Daini Hospital
Kyoto, Kyoto, Japan · Recruiting
University Hospital Kyoto Prefectural University of Medicine
Kyoto, Kyoto, Japan · Recruiting
Nagasaki University Hospital
Nagasaki, Nagasaki, Japan · Recruiting
Kawasaki Medical School Hospital
Kurashiki, Okayama-ken, Japan · Recruiting
Kansai Medical University Hospital
Hirakata, Osaka, Japan · Recruiting
Osaka National Hospital
Osaka, Osaka, Japan · Recruiting
Osaka Keisatsu Hospital
Osaka, Osaka, Japan · Recruiting
Osaka General Medical Center
Osaka, Osaka, Japan · Recruiting
Kindai University Hopital
Sakai, Osaka, Japan · Recruiting
The University of Osaka Hospital
Suita, Osaka, Japan · Recruiting
Saitama Medical University International Medical Center
Hidaka, Saitama, Japan · Recruiting
Japanese Red Cross Saitama Hospital
Saitama, Saitama, Japan · Recruiting
Dokkyo Medical University Hospital
Mibu, Tochigi, Japan · Recruiting
Jichi Medical University Hospital
Shimotsuke, Tochigi, Japan · Recruiting
Tokushima University Hospital
Tokushima, Tokushima, Japan · Recruiting
Tokyo Women's Medical University Adachi Medical Center
Adachi-ku, Tokyo, Japan · Recruiting
Institute of Science Tokyo Hospital
Bunkyō-Ku, Tokyo, Japan · Recruiting
Nippon Medical School Hospital
Bunkyō-Ku, Tokyo, Japan · Recruiting
Showa General Hospital
Kodaira, Tokyo, Japan · Recruiting
Showa Medical University Koto Toyosu Hospital
Koto-ku, Tokyo, Japan · Not yet recruiting
The Jikei University Hspital
Minato-Ku, Tokyo, Japan · Recruiting
Tokyo Saiseikai Central Hospital
Minato-Ku, Tokyo, Japan · Recruiting
Kyorin University Hospital
Mitaka, Tokyo, Japan · Recruiting
Toho University Omori Medical Center
Ōta-ku, Tokyo, Japan · Not yet recruiting
Tokyo Medical University Hospital
Shinjuku-Ku, Tokyo, Japan · Recruiting
Tokyo Women's Medical University Hospital
Shinjuku-Ku, Tokyo, Japan · Recruiting
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.